Related Experiment Video
Updated: Aug 13, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: July 1, 2013
HIV Nef-mediated major histocompatibility complex class I down-modulation is independent of Arf6 activity
Jakob E Larsen1, Ramiro H Massol, Thomas J F Nieland
1Department of Cell Biology and The Center for Blood Research, Harvard Medical School, Boston, Massachusetts 02115, USA.
Insights
The human immunodeficiency virus Nef protein down-regulates MHC class I, but this effect is not dependent on Arf6. Nef-mediated MHC class I down-modulation results from nonspecific membrane traffic disruptions.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- The human immunodeficiency virus (HIV) Nef protein modulates crucial immune molecules like CD4 and MHC class I.
- While CD4 down-regulation involves clathrin-dependent endocytosis, the mechanism for MHC class I down-regulation by Nef is unclear.
- Previous studies suggested Nef utilizes Arf6 to mediate MHC class I endocytosis.
Purpose of the Study:
- To investigate the role of Arf6 in Nef-mediated MHC class I down-regulation.
- To determine if Nef's effect on MHC class I is dependent on specific Arf6 signaling pathways.
- To clarify the mechanisms underlying Nef-induced MHC class I internalization.
Main Methods:
- Utilized specific Arf6 mutants to probe GDP-GTP cycling.
- Assessed MHC class I down-modulation in the presence of Arf6 mutants.
- Inhibited phosphatidylinositol-3-phosphate kinase (PI3K), an upstream Arf6 activator.
- Tracked MHC class I localization within the cell.
Main Results:
- MHC class I down-regulation by Nef was not affected by specific Arf6 mutants.
- Inhibition of PI3K did not alter MHC class I internalization but impacted its transport to the trans-Golgi network.
- These findings challenge the proposed direct role of Arf6 in Nef-mediated MHC class I endocytosis.
Conclusions:
- The observed Arf6 dependency in previous studies is likely due to nonspecific effects on membrane trafficking pathways.
- Nef-mediated MHC class I down-regulation does not directly involve Arf6-dependent endocytosis.
- Further research is needed to elucidate the precise molecular mechanisms of Nef's interaction with MHC class I trafficking.
Abstract:
HIV Nef has a number of important biological effects, including the down-modulation of several immunological important molecules (CD4, major histocompatibility complex [MHC] class I). Down-modulation of CD4 seems to be via clathrin-dependent endocytosis, whereas down-modulation of MHC class I remains unexplained. Several mutant proteins, including mutations in the small GTPase Arf6, have been used to probe membrane traffic pathways. One such mutant has recently been used to propose that Nef acts through Arf6 to activate the endocytosis of MHC class I. Here, we show that MHC class I down-modulation is unaffected by other Arf6 mutants that provide more specific perturbations in the GDP-GTP cycling of Arf6. Inhibition of phosphatidylinositol-3-phosphate kinase, an upstream activator of Arf6, also had no effect on the internalization step, but its activity is required to direct MHC class I to the trans-Golgi network. We conclude that the apparent Arf6 dependency of Nef-mediated MHC class I down-modulation is due to nonspecific perturbations in membrane traffic.
More Related Videos
08:11Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.
Published on: September 1, 2015
08:07Assessing the Expression of Major Histocompatibility Complex Class I on Primary Murine Hippocampal Neurons by Flow Cytometry
Published on: May 19, 2020
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly